Translational Oncology & Clinical Trials

Translational oncology connects laboratory discoveries with clinical applications and supports the development of new diagnostic and therapeutic approaches. This session covers the full pathway from preclinical investigation to early- and late-phase clinical trials, biomarker-driven studies, innovative trial designs, and implementation into patient care.

Abstract Scope and Participation

Submissions may include translational research, early-phase trials, randomized clinical trials, adaptive and basket trials, biomarker-driven studies, trial methodology, patient recruitment, regulatory science, and clinical implementation. Investigators, clinicians, trialists, statisticians, industry professionals, and regulatory researchers are invited.